ENLIGHT Meeting Novel Imaging Systems WP1: Time-of-flight in-beam PET (TERA, INFN, IFIC/CSIC, IN2P3, OncoRay, CERN, PoliAnnecy, Oxford) WP2: In-beam single.

Slides:

Advertisements

Similar presentations

Nuclear Physics in Medicine Chapter: Medical Imaging NuPECC liaisons Alexander Murphy and Faiçal Azaiez Conveners Jose Manuel Udias and David Brasse.

Advertisements

From Physics to Medicine: Hadron Therapy

Radiobiology Annelie E. Meijer.

Maria Grazia Pia, INFN Genova CERN, 26 July 2004 Background of the Project.

Detector technologies: from particle physics to radiotherapy

ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010 Susanna I Lee, MD, PhD, Chair Massachusetts General Hospital.

Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.

Milestones M5 and M6 Mid-Term Review, October 2013M. Silari – ARDENT overview1 M5: comparison of detector technologies (WP1) M6: choice of detector technology.

M. Silari - The ARDENT ITN project 1EURADOS, Vienna, 7-10 February 2012 ARDENT February 2012 – January 2016 Advanced Radiation Dosimetry European Network.

24 September 2008 ENLIGHT, ESF Workshop-Oxford European Network for Light Ion Therapy ENLIGHT Manjit Dosanjh ENLIGHT Coordinator & CERN.

Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,

Other Issues Manpower J. Apostolakis Geant4  Review 2009.

Summer Practice in JINR Mathematical modeling of high-energy particle beams in accelerators.

From Physics to Health applications: challenges and benefits Serbia Detector School, 13 September 2014 Manjit Dosanjh, CERN.

1 Dosimetric Optimization of Interstitial Gene Therapy Delivery Systems The Gynecologic Disease Program 1 Georgetown University Med. Ctr. 2 Walter Reed.

Wolfgang Enghardt Technische Universität Dresden, Germany OncoRay – Center for Radiation Research in Oncology and Forschungszentrum Dresden-Rossendorf,

ENLIGHT- PARTNER Meeting, June 2009, IFIC- Valencia Manjit DOSANJH ENLIGHT Coordinator & CERN.

October 16thPicosecond Lyon1 INNOTEP Project Using HEP technologies to improve TEP imaging: Development of innovative schemes for front-end electronic,

75 th Annual Meeting March 2011 Imaging with, spatial resolution of, and plans for upgrading a minimal prototype muon tomography station J. LOCKE, W. BITTNER,

March 2011 CERN, Geneva European Training Network for Particle Therapy Founded by the European Commission PARTNER.

Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program 21 March 2014 Matteo Castoldi

Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 2 nd of December 2014 Giovanni.

RARECARENet: how will we work together?. Information network on rare cancers Advisory Board The Coordinator (Project Management Team) Steering Committee.

TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.

Present & Future of Accelerators for Hadrontherapy A. Faus-Golfe IFIC-IFIMED June 20091IFIMED'09 Symposium.

Enhancing InBeam PET with single Photon (Compton) Detection CERN September 2nd 2008 VALENCIA GROUP, IFIMED José M. Benlloch (PET hardware, speaker) José.

CERN in everyday life H F Hoffmann CERN honorary 1 CERN technologies in daily life H. F. Hoffmann/CERN honorary Globally networked science Competent.

Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,

Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.

A telephone conference (14 th of December) with the four of us in order to discuss the following issues: - identify the subjects to be covered in the report.

NCB Noël Barengo, MD, PhD, MPH Department of Public Health University of Helsinki, Finland Unit of Clinical Research, University Hospital La Paz,

GATE Monte Carlo simulation platform

Philip Burrows TIARA Preparation Board, CERN, 2/11/091 TIARA WP5 Philip Burrows John Adams Institute for Accelerator Science Oxford University.

Philip Burrows TIARA Preparation Board, CERN, 14/10/091 TIARA WP5 preparation status Philip Burrows John Adams Institute for Accelerator Science Oxford.

Text optional: Institutsname Prof. Dr. Hans Mustermann Mitglied der Leibniz-Gemeinschaft `Cross disciplinary applications` Annual Meeting and.

Wolfgang Enghardt OncoRay – Center for Radiation Research in Oncology Technische Universität Dresden, Germany and Forschungszentrum Dresden-Rossendorf,

ENVISION Activities Overview of the IRIS group John Barrio, Jorge Cabello, Pablo García, John Gillam, Gabriela Llosá, Paola Solevi, Carlos Lacasta, Josep.

CONFIDENTIAL MATERIAL Michele Togno - II Annual ARDENT Meeting, Milan – October, 14 th D Ionization Chambers Array for Clinical Applications.

Frédérick BORDRY, CMASC – 1 st Meeting 30 th March 2016 New structure of CERN Medical Applications CMASC : CERN Medical Applications Steering Committee.

J Cho, G Ibbott, M Kerr, R Amos, and O Mawlawi

J Cho, G Ibbott, M Gillin, C Gonzalez-Lepera, U Titt and O Mawlawi

Training, Communications and Outreach

ARIES Industrial and Societal Applications Network

Medical Applications Knowledge Transfer | Accelerating Innovation.

Education & Training NA

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment Tjeerd S. Aukema, MD, Renato.

IT Steering Committee 6/9/2018 BEGIN - CONTINGENCY.

Status and main challenges for detectors in Hadron Therapy European Radiation Detection and Imaging.

WP4: Applications of Accelerators

CLIC-Spain collaboration report

Presented by : José F. Salt Cairols

ICT Division of CIEMAT in GISELA

EU Institution Board 1 representative of each participating institute

Clinical Application of Therapies Targeting VEGF

Giulio Magrin, TERA Foundation, Manjit Dosanjh, ENLIGHT++, CERN

Freedom from secondary interventions to treat stenotic disease after percutaneous transluminal angioplasty of infrarenal aorta: long-term results J.P.P.M.

Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience Idris A. Elbakri,

Electronic Clinical Challenges and Images in GI

!'!!. = pt >pt > \ ___,..___,..

Ivana M. M. van der Geest, BSc, Anne-Sophie E

Physics and Imaging in Radiation Oncology

Evolving Role of PET-Computed Tomography and PET-MR Imaging in Assessment of Musculoskeletal Disorders and Its Potential Revolutionary Impact on Day-to-Day.

A Markov Decision Model to Guide Treatment of Recurrent Colonic Diverticulitis Caroline S. Andeweg, Johannes Groenewoud, Gert Jan van der Wilt, Harry.

Vertebral Collapse Caused by Bone Metastasis

Volume 27, Issue 3, Pages xvii-xviii (August 2017)

Multidisciplinary Physic

Clinical Challenges and Images in GI

Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma Naoyuki.

PET Imaging of Infection and Inflammation

Presentation transcript:

ENLIGHT Meeting Novel Imaging Systems WP1: Time-of-flight in-beam PET (TERA, INFN, IFIC/CSIC, IN2P3, OncoRay, CERN, PoliAnnecy, Oxford) WP2: In-beam single particle tomography (TERA, IBA, ICX, IFIC/CSIC, In2P3,Etoile,OncoRay) WP3: PT in-vivo dosimetry and moving target volumes (GSI, HIT, Oncoray, PoliMilano, Oxford, IBA, Etoile, IFIC/CSIC, INFN, Siemens?, Marburg? TERA) WP4: The combination of in-vivo dosimetry, treatment planning, and clinical relevance (BHTC, MUVienna, Oxford, INFN, Siemens, Etoile, Marburg) WP5: Monte Carlo Simulation of in-vivo dosimetry (CERN, INFN, Ciemat, IFIC, PoliAnnecy, HIT, OncoRay, IN2P3, Etoile, IBA)

ENLIGHT Meeting Novel Imaging Systems WP1: Time-of-flight in-beam PET (F. Sauli, M. Rafecas) WP2: In-beam single particle tomography (W. Enghardt, D. Dauvergne) WP3: PT in-vivo dosimetry and moving target volumes (K. Parodi, G. Baroni) WP4: The combination of in-vivo dosimetry, treatment planning, and clinical relevance (D. Georg, B. Jones) WP5: Monte Carlo Simulation of in-vivo dosimetry (I. Buvat?, G. Battistoni) UA, MD, ThH, KP, GM, WE, ADG

ENLIGHT Meeting Novel Imaging Systems STEERING COMMITTEE Coordinator: Manjit Dosanjh Members: Dieter Schardt Frank Van den Heuvel Carlos Lacasta Gerard Montarou … UA, JB, J-MM

Manjit Dosanjh TERA INFN IFIC/CSIC IN2P3 OncoRay CERN PoliAnnecy Oxford IBA ICX Etoile GSI HIT PoliMilano Siemens Marburg BHTC MUVienna Ciemat Possible partner SME? TERA/CNAO/PoliMilano/UBern INFN IFIC-CSIC/Ciemat IN2P3/CEA? OncoRay CERN Oxford IBA ICX Etoile/ PoliAnnecy/Archade? GSI HIT/Marburg Siemens BHTC MUVienna Possible partner XYSME? FIRST LISTSECOND LIST